The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
分析师的判决：6位专家眼中的Roivant Sciences
6 analysts have shared their evaluations of Roivant Sciences (NASDAQ:ROIV) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三个月来，有6位分析师分享了他们对Roivant Sciences（纳斯达克股票代码：ROIV）的评估，表达了看涨和看跌的观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Roivant Sciences, revealing an average target of $18.33, a high estimate of $23.00, and a low estimate of $15.00. Observing a 12.8% increase, the current average has risen from the previous average price target of $16.25.
分析师为Roivant Sciences设定了12个月的目标股价，显示平均目标股价为18.33美元，最高估计为23.00美元，低估值为15.00美元。目前的平均价格上涨了12.8％，已从之前的平均目标价16.25美元上涨。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
A comprehensive examination of how financial experts perceive Roivant Sciences is...
对金融专家如何看待Ro...
登录免费看全文
登录/注册